Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD) in later life. We aimed to study the effect of liraglutide intervention on markers of VTE and CVD risk, in PCOS. In a double-blind, placebo-controlled, randomized tria...

Full description

Bibliographic Details
Main Authors: Malin Nylander, Signe Frøssing, Caroline Kistorp, Jens Faber, Sven O Skouby
Format: Article
Language:English
Published: Bioscientifica 2017-01-01
Series:Endocrine Connections
Subjects:
polycystic ovary syndrome
liraglutide
GLP-1 analog
thrombin generation
plasminogen activator inhibitor-1
low-grade inflammation
Online Access:http://www.endocrineconnections.com/content/6/2/89.full

Internet

http://www.endocrineconnections.com/content/6/2/89.full

Similar Items